Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort study
Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María José García Blanco, José López Miranda, Juan Luis Romero Cabrera, Carmen Rosario Herrero Gil, J Bascunana, Manuel Rubio-Rivas, Sara Pintos Otero, Verónica Martínez Sempere, Jesús Ballano Rodríguez-Solís, Ricardo Gil Sánchez, Jairo Luque del Pino, Amara González Noya, MS Navas-Alcántara, Begoña Cortés Rodríguez, José N. Alcalá, Ana Suárez-Lombraña, Jorge Andrés Soler, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Jesús Millán Núñez-Cortés, for the SEMI-COVID-19 Network^
doi: https://doi.org/10.1101/2021.02.24.21252391
Emilia Roy-Vallejo
1Internal Medicine Department, La Princesa University Hospital, Instituto de Investigación -La Princesa Biomedical Research Foundation, Universidad Autónoma de Madrid, Madrid, Spain
Aquilino Sánchez Purificación
2Internal Medicine Department, La Paz University Hospital, Madrid, Spain
José David Torres Peña
3Lipids and Atherosclerosis Unit, Internal Medicine Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, Córdoba, Spain
Beatriz Sánchez Moreno
1Internal Medicine Department, La Princesa University Hospital, Instituto de Investigación -La Princesa Biomedical Research Foundation, Universidad Autónoma de Madrid, Madrid, Spain
Francisco Arnalich
2Internal Medicine Department, La Paz University Hospital, Madrid, Spain
María José García Blanco
1Internal Medicine Department, La Princesa University Hospital, Instituto de Investigación -La Princesa Biomedical Research Foundation, Universidad Autónoma de Madrid, Madrid, Spain
José López Miranda
3Lipids and Atherosclerosis Unit, Internal Medicine Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, Córdoba, Spain
Juan Luis Romero Cabrera
3Lipids and Atherosclerosis Unit, Internal Medicine Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, Córdoba, Spain
Carmen Rosario Herrero Gil
2Internal Medicine Department, La Paz University Hospital, Madrid, Spain
J Bascunana
4Internal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain
Manuel Rubio-Rivas
5Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain
Sara Pintos Otero
6Internal Medicine Department, Zamora Hospital Complex, Zamora, Spain
Verónica Martínez Sempere
7Internal Medicine Department, San Juan de Alicante University Hospital, San Juan de Alicante (Alicante), Spain
Jesús Ballano Rodríguez-Solís
8Internal Medicine Department, Henares Hospital, Coslada (Madrid), Spain
Ricardo Gil Sánchez
9Internal Medicine Department, La Fe University Hospital, Valencia, Spain
Jairo Luque del Pino
10Internal Medicine Department, Costa del Sol Hospital, Marbella (Málaga), Spain
Amara González Noya
11Internal Medicine Department, Ourense University Hospital Complex, Ourense, Spain
MS Navas-Alcántara
12Internal Medicine Department, Infanta Margarita Hospital, Cabra (Córdoba), Spain
Begoña Cortés Rodríguez
13Internal Medicine Department, Alto Guadalquivir Hospital, Andújar (Jaén), Spain
José N. Alcalá
14Internal Medicine Department, Pozoblanco Hospital, Pozoblanco (Córdoba), Spain
Ana Suárez-Lombraña
15Internal Medicine Department, Platón Hospital, Barcelona, Spain
Jorge Andrés Soler
16Internal Medicine Department, Castellón University General Hospital, Castellón de la Plana, Spain
Ricardo Gómez Huelgas
17Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Málaga, Spain
José Manuel Casas Rojo
18Internal Medicine Department, Infanta Cristina University Hospital, Parla (Madrid), Spain
Jesús Millán Núñez-Cortés
19Internal Medicine Department, Gregorio Marañón University Hospital, Madrid, Spain
Posted February 25, 2021.
Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort study
Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María José García Blanco, José López Miranda, Juan Luis Romero Cabrera, Carmen Rosario Herrero Gil, J Bascunana, Manuel Rubio-Rivas, Sara Pintos Otero, Verónica Martínez Sempere, Jesús Ballano Rodríguez-Solís, Ricardo Gil Sánchez, Jairo Luque del Pino, Amara González Noya, MS Navas-Alcántara, Begoña Cortés Rodríguez, José N. Alcalá, Ana Suárez-Lombraña, Jorge Andrés Soler, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Jesús Millán Núñez-Cortés, for the SEMI-COVID-19 Network^
medRxiv 2021.02.24.21252391; doi: https://doi.org/10.1101/2021.02.24.21252391
Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort study
Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María José García Blanco, José López Miranda, Juan Luis Romero Cabrera, Carmen Rosario Herrero Gil, J Bascunana, Manuel Rubio-Rivas, Sara Pintos Otero, Verónica Martínez Sempere, Jesús Ballano Rodríguez-Solís, Ricardo Gil Sánchez, Jairo Luque del Pino, Amara González Noya, MS Navas-Alcántara, Begoña Cortés Rodríguez, José N. Alcalá, Ana Suárez-Lombraña, Jorge Andrés Soler, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Jesús Millán Núñez-Cortés, for the SEMI-COVID-19 Network^
medRxiv 2021.02.24.21252391; doi: https://doi.org/10.1101/2021.02.24.21252391
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2359)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11748)
- Forensic Medicine (10)
- Gastroenterology (700)
- Genetic and Genomic Medicine (3714)
- Geriatric Medicine (348)
- Health Economics (632)
- Health Informatics (2385)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3477)
- Nursing (197)
- Nutrition (522)
- Oncology (1813)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1028)
- Primary Care Research (417)
- Public and Global Health (6122)
- Radiology and Imaging (1270)
- Respiratory Medicine (825)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)